View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 28, 2018

Philips develops new resuscitation device for infants

Royal Philips has developed a resuscitation device in collaboration with the Consortium for Affordable Medical Technologies (CAMTech) at Massachusetts General Hospital Global Health to help reduce neonatal mortality.

Royal Philips has developed a resuscitation device in collaboration with the Consortium for Affordable Medical Technologies (CAMTech) at Massachusetts General Hospital Global Health to help reduce neonatal mortality.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Referred to as the Augmented Infant Resuscitator (AIR), the new device could be used as an add-on product for standard neonatal bag-valve-mask (BVM) resuscitators used by caregivers to resuscitate asphyxiated newborn babies.

AIR is intended to minimise neonatal mortality primarily in regions with underserved healthcare conditions. The device will initially be launched in limited volume in certain markets and thereafter in low- and middle-income countries.

“Phillips said that effective resuscitation can potentially lead to a 30% decrease in such neonatal deaths and a 10% reduction in deaths from prematurity.”

Royal Philips Therapeutic Care business leader Arman Voskerchyan said: “By combining our expertise in respiratory care and resuscitation with the strengths of global health innovators like the AIR team at CAMTech, we aim to drive and scale innovative solutions that bridge societal divides in healthcare to reach underserved populations, and thereby addressing the United Nations Sustainable Development Goal 3.”

Birth asphyxia causes damage to vital organs in newborns. It is known to result in more than 800,000 neonatal deaths per year.

Phillips said that effective resuscitation can potentially lead to a 30% decrease in such neonatal deaths and a 10% reduction in deaths from prematurity.

AIR works by measuring ventilation flow and pressure in order to monitor the ventilation quality.

The resuscitation device offers visual feedback on common ventilation-related errors such as an inadequate face-mask seal, incorrect ventilation rate, obstructed airways and harsh breaths.

Such errors are said to be associated with permanent neurological injury and death.

The device records performance to enable future feedback and improve the training of healthcare professionals by highlighting persistent gaps in technique.

Initially, the CAMTech team developed the prototype of AIR in 2012. The researchers further developed the device, along with Philips, in 2016.

AIR was assessed in a multi-centre, randomised clinical trial of 270 birth attendants in Uganda and the US CAMTech intends to conduct a separate multi-country trial in India, Uganda and Ghana, and Philips will supply more than 200 engineering samples for this study.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network